Skip to main content
. 2018 Dec 18;34(5):855–863. doi: 10.1007/s00467-018-4172-3

Table 2.

6, 12, and 24-month event-free survival (EFS) at different doses—first treatment only

Dosing strategy Total number of doses 6-month EFS 12-month EFS 24-month EFS
High 14 12/14 (85.7%) 7/14 (50.0%) 4/14 (28.6%)
Intermediate 5 5/5 (100%) 4/4 (100%) 3/4 (75.0%)
Low 40 30/37 (81.1%) 13/34 (38.2%) 2/30 (6.7%)
Chi-squared value 1.213 5.608 12.069
p value NS 0.06 0.0024